Liu, Dan
Li, Bing
Xu, Zefeng
Zhang, Peihong
Qin, Tiejun
Qu, Shiqiang
Pan, Lijuan
Sun, Xiujuan
Shi, Zhongxun
Huang, Huijun
Wang, Huijun
Gale, Robert Peter
Xiao, Zhijian http://orcid.org/0000-0002-1099-4489
Article History
Received: 7 July 2021
Revised: 21 August 2021
Accepted: 27 August 2021
First Online: 8 September 2021
Competing interests
: RPG is a consultant to BeiGene Ltd., Fusion Pharma LLC, LaJolla NanoMedical Inc., Mingsight Parmaceuticals Inc. and CStone Pharmaceuticals; advisor to Antegene Biotech LLC, Medical Director, FFF Enterprises Inc.; partner, AZAC Inc.; Board of Directors, Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.